Carcinoma de páncreas

Metastásico

Erlotinib + Gemcitabina en primera línea - NCI Canada

- Moore MJ, Goldstein D, Hamm J, et al.Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007 25: 1960-1966

Gemcitabina es superior a Fluoruracilo - GemcPancr

- Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997 15: 2403-2413